Down-regulation of ZNF252P-AS1 led to a significant increase in miR-324-3p expression in ovarian cancer cells, and the transfection of miR-324-3p inhibitor effectively inhibited miR-324-3p expression (Fig. 5A). Here, ZNF252P is linked to ovarian cancer.